These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The thrombogenicity of Dacron arterial grafts and its modification by platelet inhibitory drugs. Kester RC. Ann R Coll Surg Engl; 1984 Jul; 66(4):241-6. PubMed ID: 6234841 [Abstract] [Full Text] [Related]
4. Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood. Baumgartner HR. Haemostasis; 1979 Jul; 8(3-5):340-52. PubMed ID: 511014 [Abstract] [Full Text] [Related]
5. Platelet inhibitory drugs: an in vivo method of evaluation in patients. Norcott HC, Goldman M, Hawker RJ, Rafiqi EI, Drolc Z, McCollum CN. Thromb Haemost; 1982 Dec 27; 48(3):307-10. PubMed ID: 6761890 [Abstract] [Full Text] [Related]
6. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man. Lorenz R, Siess W, Weber PC. Eur J Pharmacol; 1981 Apr 09; 70(4):511-8. PubMed ID: 7238575 [Abstract] [Full Text] [Related]
7. Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole. Oblath RW, Buckley FO, Green RM, Schwartz SI, DeWeese JA. Surgery; 1978 Jul 09; 84(1):37-44. PubMed ID: 149385 [No Abstract] [Full Text] [Related]
8. Aspirin and other platelet-aggregation inhibiting drugs. Gallus AS. Med J Aust; 1985 Jan 07; 142(1):41-7. PubMed ID: 3880861 [Abstract] [Full Text] [Related]
13. Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers. Cadroy Y, Thalamas C, Sakariassen K, Boneu B. Thromb Res; 2005 Jan 07; 116(4):293-300. PubMed ID: 16038713 [Abstract] [Full Text] [Related]
14. Effects of dipyridamole and low-dose aspirin therapy on platelet adhesion to vascular subendothelium. Lauri D, Zanetti A, Dejana E, de Gaetano G. Am J Cardiol; 1986 Dec 01; 58(13):1261-4. PubMed ID: 3788816 [Abstract] [Full Text] [Related]
15. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors]. Oelz O. Schweiz Med Wochenschr; 1979 Mar 10; 109(10):348-53. PubMed ID: 424707 [Abstract] [Full Text] [Related]
16. Evaluation of the thrombogenic potential of three types of arterial graft studied in an artificial circulation. Hamlin GW, Rajah SM, Crow MJ, Kester RC. Br J Surg; 1978 Apr 10; 65(4):272-6. PubMed ID: 147719 [Abstract] [Full Text] [Related]
17. The influence of red blood cells on the effects of aspirin or sulphinpyrazone on platelet adherence to damaged rabbit aorta. Davies JA, Essien E, Cazenave JP, Kinlough-Rathbone RL, Gent M, Mustard JF. Br J Haematol; 1979 Jun 10; 42(2):283-91. PubMed ID: 465372 [Abstract] [Full Text] [Related]
18. In vivo quantitation of platelet deposition on human peripheral arterial bypass grafts using indium-111-labeled platelets. Effect of dipyridamole and aspirin. Pumphrey CW, Chesebro JH, Dewanjee MK, Wahner HW, Hollier LH, Pairolero PC, Fuster V. Am J Cardiol; 1983 Mar 01; 51(5):796-801. PubMed ID: 6219569 [Abstract] [Full Text] [Related]